Analysis of the cost‐effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan

Abstract Background Proton beam therapy (PBT) has recently been included in Japan's social health insurance benefits package. This study aimed to determine the cost‐effectiveness of PBT for unresectable, locally advanced pancreatic cancer (LAPC) as a replacement for conventional photon radiotherapy...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yuichi Hiroshima, Masahide Kondo, Takuya Sawada, Shu‐ling Hoshi, Reiko Okubo, Takashi Iizumi, Haruko Numajiri, Toshiyuki Okumura, Hideyuki Sakurai
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2023-10-01
Ráidu:	Cancer Medicine
Fáttát:	chemoradiotherapy cost‐effectiveness incremental cost‐effectiveness ratio locally advanced pancreatic cancer particle radiotherapy proton beam therapy
Liŋkkat:	https://doi.org/10.1002/cam4.6611
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!